Tahir Hamid

Tahir Hamid has been working as an Interventional Cardiology Consultant with the Heart Hospital, Hamad Medical Corporation, Doha Qatar. He has been trained in U.K., and at the University of Toronto, Toronto, ON, Canada. He has about 27 publications and presented at various cardiology conferences. He is currently a MRCP in U.K., and FESC. He is also conducting randomized control trial about pre-procedural fasting in patients undergoing coronary interventions at the Toronto General Hospital, University of Toronto. He has published the following study related to ECG monitoring in patients with recurrent blackouts: Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy - REVISE study, Europace. November 2012;14(11):1653-60. This study revolutionized the assessment of patient blackout who were wrongly labeled as epileptics and were later found after prolonged monitoring, to have cardiac rhythm related issues leading to blackouts. He is also actively involved in the research projects at Hamad Medical Corporation. He is also working on his project about external cardiopulmonary resuscitation devices for patients who sustain cardiac arrests.